Condition: Small Cell Lung Cancer Metastatic or Locally Advanced · Neuroendocrine Cancer · Metastatic Neuroendocrine Prostate Cancer · Sponsor: SystImmune Inc.
The objective of this study is to evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of BL-M14D1 in Subjects with locally Advanced or Metastatic Small Cell Lung Cancer and Other Neuroendocrine Neoplasms
This description comes directly from the study's public registry record.
Lien Huzzy · 4254536841 · lien.huzzy@systimmune.com
Whitney Eakins · 4254536841 · whitney.eakins@systimmune.com
Always discuss trial participation with your own doctor first.
| Clearview Cancer Institute | Huntsville, Alabama, United States | Not Yet Recruiting |
| Valkyrie Clinical Trials | Los Angeles, California, United States | Recruiting |
| UCLA | Los Angeles, California, United States | Not Yet Recruiting |
| UCSF- San Francisco (Helen Diller Family Comprehensive Cancer Center) | San Francisco, California, United States | Not Yet Recruiting |
| University of Colorado - Anschutz Cancer Pavilion | Aurora, Colorado, United States | Recruiting |
| Yale Cancer Center | New Haven, Connecticut, United States | Recruiting |
| Emory Winship | Atlanta, Georgia, United States | Recruiting |
| John Theurer Cancer Center-Hackensack | Hackensack, New Jersey, United States | Recruiting |
| Rutgers Cancer Institute | New Brunswick, New Jersey, United States | Recruiting |
| Icahn School of Medicine at Mount Sinai | New York, New York, United States | Recruiting |
| Ohio State University | Columbus, Ohio, United States | Recruiting |
| Providence Cancer Institute | Portland, Oregon, United States | Recruiting |
+ 8 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07080242